MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 10.11.2025
Cabaletta Bio EV 2011-2026 | CABA
EV Jährlich Cabaletta Bio
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -155 M | -23.1 M | -4.21 M | -95.9 M | 278 M | 44.9 M | 250 K | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 278 M | -155 M | 6.42 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M |  Germany |
 |
Alector
ALEC
|
444 M | $ 2.08 | -14.4 % | $ 214 M |  USA |
 |
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | USA |
 |
BioCardia
BCDA
|
12.4 M | $ 1.36 | 5.04 % | $ 28.8 M | USA |
 |
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M |  China |
 |
BioLineRx Ltd.
BLRX
|
15 M | $ 2.8 | -1.06 % | $ 908 M |  Israel |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | USA |
 |
AgeX Therapeutics
AGE
|
6.28 M | - | -10.17 % | $ 12.2 K | USA |
 |
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M |  France |
 |
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | USA |
 |
BioXcel Therapeutics
BTAI
|
107 M | $ 1.63 | -2.37 % | $ 4.13 M | USA |
 |
AbCellera Biologics
ABCL
|
1.22 B | $ 3.65 | 0.97 % | $ 1.09 B |  Canada |
 |
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M | - | - | $ 26.5 M | USA |
 |
Burford Capital Limited
BUR
|
3.22 B | $ 8.81 | 4.38 % | $ 1.39 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | Britain |
 |
BeyondSpring
BYSI
|
149 M | $ 1.36 | 0.37 % | $ 54.8 M | USA |
 |
Black Diamond Therapeutics
BDTX
|
107 M | $ 2.38 | -3.64 % | $ 131 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 4.83 | 1.68 % | $ 10.5 B | Israel |
 |
Capricor Therapeutics
CAPR
|
177 M | $ 26.89 | -3.72 % | $ 720 M | USA |
 |
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M | USA |
 |
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | USA |
 |
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | Canada |
 |
Catalyst Biosciences
CBIO
|
38.1 M | $ 11.55 | -4.47 % | $ 760 M | USA |
 |
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
AIkido Pharma
AIKI
|
22.8 M | - | 1.93 % | $ 17.4 M | USA |
 |
C4 Therapeutics
CCCC
|
262 M | $ 3.04 | 12.59 % | $ 252 M | USA |
 |
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
-14.1 M | - | 3.16 % | $ 1.9 M | USA |
 |
Codexis
CDXS
|
354 M | $ 1.08 | 6.93 % | $ 79.3 M | USA |
 |
Aileron Therapeutics
ALRN
|
33.1 M | - | 10.36 % | $ 9.8 M | USA |
 |
AlloVir
ALVR
|
-64.1 M | - | 4.14 % | $ 49.1 M | USA |
 |
Alpine Immune Sciences
ALPN
|
363 M | - | - | $ 2.17 B | USA |
 |
Cerus Corporation
CERS
|
425 M | $ 2.64 | 2.93 % | $ 487 M | USA |
 |
Certara
CERT
|
1.38 B | $ 7.17 | 1.2 % | $ 1.15 B | USA |
 |
Aeterna Zentaris
AEZS
|
5.52 M | - | 5.93 % | $ 314 M | Canada |
 |
Cullinan Management
CGEM
|
458 M | $ 15.87 | 2.39 % | $ 929 M | USA |
 |
Compugen Ltd.
CGEN
|
291 M | $ 2.24 | 23.76 % | $ 201 M | Israel |
 |
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | USA |
 |
Coherus BioSciences
CHRS
|
929 M | $ 1.66 | -0.9 % | $ 156 M | USA |
 |
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | USA |
 |
Aptose Biosciences
APTO
|
10.8 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-18.3 M | - | -39.0 % | $ 4.57 M | USA |
 |
Celldex Therapeutics
CLDX
|
2.07 B | $ 30.18 | 0.3 % | $ 2 B | USA |
 |
Cellectis S.A.
CLLS
|
109 M | $ 3.88 | - | $ 116 M | France |